CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows From Operating Activities:
Net loss	$ (16,941,010)	$ (11,792,369)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	1,483,156	473,084
Change in fair value of derivative instrument-warrants	1,871,457	(3,218,846)
Change in fair value of contingent consideration	1,170,000
Depreciation and amortization expense	21,492	16,124
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	(2,599,509)	2,350,563
Prepaid expenses and other assets	71,197	11,590
Net Cash used in Operating Activities	(14,923,217)	(12,159,854)
Cash Flows From Investing Activities:
Purchases of property and equipment	(12,284)	(6,603)
Net Cash Used in Investing Activities	(12,284)	(6,603)
Cash Flows From Financing Activities:
Current portion of capital lease	(10,410)
Proceeds from the issuance of common stock and warrants, net	13,563,159	13,525,960
Proceeds from exercise of warrants	85,000
Proceeds from the exercise of stock options	31,277	34,093
Net Cash provided by Financing Activities	13,669,026	13,560,053
Net increase\(decrease) in cash	(1,266,475)	1,393,596
Cash at beginning of period	7,403,940	4,563,165
Cash at end of period	6,137,465	5,956,761
Supplementary Disclosure Of Non-Cash Financing Activities:
Fair value of warrants issued in conjunction with common stock offering		$ 4,384,523
Series A convertible preferred stock
Supplementary Disclosure Of Non-Cash Financing Activities:
Conversion of convertible preferred stock	11,459,872
Series B convertible preferred stock
Supplementary Disclosure Of Non-Cash Financing Activities:
Conversion of convertible preferred stock	$ 1,200,000